wow this is rich. Pup giving warnings about exploitation. Since we are having fun with legal latin phrases, I remember one, Falsus in unum, falsus in omnibus. The pup who cried wolf, no one believes the pup about anything.
good point flog. the timeline for rigs could and should be quicker than now planned if expected good results from the trial actually happen. manocept and rigs, wow could you imagine what this company would be worth then. Lets hope Ls becomes the s.o.c. as the company says in 12 to 18 months to fund the whole pipeline. I enjoyed dr williams explaining the science involved in the manocept platform at the recent conference and your" pipeline within a product " statement sums it up eloquently.
I would hate to see a 8 dollar buyout before rigs and the manocept platform get near completion. Very promising science worth billions......
pup does rub elbows with ge upper mgmt. He has his own shine box just outside hq.Word has it you can see youself in his spit shine when looking down.Mgmt lightheartedly calls him doc while laying a sawbuck on him.
i see your point, but as a investor i am thinking the next 3 years will be very important. Good luck with predicting the short term ebbs and flows.
quite a record of acquisitions, navb will certainly be a worthwhile target going forward. exciting to think where this company could be in the coming years.
it will draw alot of attention to the product, accelerate the companies march to profitability, and help fund the the rest of the pipeline including the manocept platform and rigs which would propel this company to the stratosphere. So all in all a really good thing. Oh and maybe put a little pressure on shorty to begin to let the pps run a bit.
first off congratulations on getting in when you did. I bought at 3. Considering the markets the manocept platform would open up if approved, and the science does look promising[ dr williams spoke eloquently about it the other day at the conference, and the size of the rig scan market possible sentinel node designation for all hard tumors, the sky is the limit. I will not venture a guess at the pps as there are many others better at crunching the numbers than myself on this board. but your 3 year timeline would allow the whole pipeline to come to fruition and you will in all likely hood be playing with house money while you wait.I plan on seeing it all the way through, good luck.
Be fair to pup puta in his mind he considers himself a colleague of dr lai. "we doctors" was how he referred to himself in one of his recent diatribes.manocept , rigs, lymphatic mapping for all hard tumors, we have a huge x on our back as a future buyout. unlimited upside.
what price did you short from pup ? You must be up some good money . I invested at $3 so it is what it is for me at this time.When I invested I planned on being long so I am willing to wait it out win or lose. What is your trading strategy with navb ? In your many post I have never seen you mention YOUR investment. That is why you appear nothing more than a shill in the game which in all likelyhood is what you are.Don't you realize how transparent you are ? No need to answer really , we all know you have no skin in the game , which makes your opinions hollow and disingenious whether you are right or wrong. Like standing in the road yelling at traffic .You should stay posting on this board the rest of your life if you desire, why would investors care what you post ?Answer- we don't.
Sentiment: Strong Buy
thanks hughes , appreciate you sharing the insight you obtained from your friend. I still have high hopes for navb and its investors. Best of luck to you as well.
crux of the biscuit as they say , market share and usage proposed is what it will come down to. . You seem a proponent of the shrekli argument albeit minus the fda will not pass it in the first place prognostication. guess you dont t think the c code will help take market share or the superiority of the product or the manocept platform expanding that market even further. when you say "many surgeons today do not do sentinel node procedures in head and neck or colon or other tumors and that the procedure of removing only the positive nodes is actually more complex than removing the entire ln basin. Truly easy to understand actually." Lol , that statement proves ls immense worth in those areas actually........ less slice and dice !
Stuck and quezzy are feelings I am familiar with when I look at the pps. The game has literally just started for real for ls and navb. patience is part of the required virtues when investing in companies such as this. One does not take over the market overnight, this is not the pet rock or chia pet being sold to impuse buyers over the tv. Navb and Card health have a sales plan that will take 12 to 18 months to achieve their goal. Sounds reasonable to me.
If seek is adopted as projected cash burn will not be a issue, that much I can assure you. Oldtimers board has some numbers posted on their site for ls projected markets, which last time I looked at them[quite awhile ago} did not include the promising manocept platform. no question ls can easily carry the company forward on its back. You really should have a look as you are apparently grossly underestimating the market for ls if it succeeds.
eu approval maybe, sentinel lymph node indication maybe, exponential sales growth of lymphoseek after each passing quarter absolutely. Company said they expect ls to be the s.o.c in 12 to 18 months. If that is the reality then it will move. I couldn't tell you if manipulation is taking place to clean out retail, or if pm is behind some of it, or if the 18 to 20 million short shares have actively been attacking this stock for the last 1 1/2 years has a hand in it. But I have put my money where my mouth is when I say I expect Lymphoseek to achieve the lofty expectations of the company with Cardinal health behind it. I bought a boat load at 3 and it goes without saying I am not happy with the current pps. Bottom line pjg is either you believe in the company and their products or you don't. I will wait those 12 to 18 months and see where we are at that time hopefully with eu approval, SLN designation, positive follow ups and approvals for the manocept platform,4694 including medicaid coverage,5001, rigs continuance. Sales and covering if you please lord . Then the pps in nov 2013 won't make a difference unless you have already sold or covered be it what may.Good luck to the longs, the shorts have already received theirs.
no pjg. That is what the crede deal accomplished. They have bought the time to pursue the pipeline and let ls capture the market . They will have all of 2014 to ramp up sales.